Prime maintains CEO Cancer Gold Standard designation

Accreditation from CEO Roundtable on Cancer continues since 2012

February 17, 2021

Business leaders know cancer affects their workforces, and research confirms cancer’s impact on American workers and their families. But more than half of all cancer deaths can be prevented through early diagnosis.


“Employers report a level of complexity in managing employees’ cancer-related needs beyond that associated with any other type of disease or condition.”
Northeast Business Group on Health (NEBGH) Cancer and the Workplace: The Employer Perspective report¹


Since 2012, Prime Therapeutics has joined more than 200 companies that are recognized as a CEO Cancer Gold Standard™ organization for their efforts to reduce cancer among its employees. By focusing on cancer risk reduction, early detection, and quality care, the program can help save employee lives.

To earn Gold Standard accreditation, Prime established programs that reduce cancer risk by taking concrete actions in five key areas:

  1. Emphasize prevention by prohibiting tobacco use and supporting tobacco cessation efforts
  2. Promote healthy lifestyles through physical activity, healthy nutrition and weight management
  3. Provide health insurance options that encourage detection of cancer at its earliest stages, ensure access to quality care, and allow participation in cancer clinical trials
  4. Promote employee awareness of these initiatives, and
  5. Support the needs of cancer survivors in the workplace.

Prime’s employees are its greatest resource. By following the Gold Standard program and supporting healthy behaviors, the company is having a positive impact on them, their families and their communities.


  1. Northeast Business Group on Health. (2015, October). Cancer and the Workplace: The Employer Perspective. https://nebgh.org/wp-content/uploads/2015/10/CancerWorkplace_FINAL.pdf

Related news

Stories

October 15, 2021

Prime leaders discuss the emerging opportunity for biosimilars

MILI and Prime Therapeutics leadership led a virtual panel discussion on Oct. 13,…

Stories

October 14, 2021

Prime’s Frank Aba-Onu recognized for diversity and inclusion efforts

Frank Aba-Onu, legal counsel at Prime Therapeutics, was part of a team recognized…

Stories

September 15, 2021

Prime’s High-Value Pharmacist Managed Care pilots win PBMI Excellence Award

The Pharmacy Benefit Management Institute (PBMI) honored Prime Therapeutics’ High-Value Pharmacist Managed Care…